
|Articles|January 1, 2002
Griseofulvin should remain standard in tinea capitis
Munich - Newer oral antifungals have efficacy similar to griseofulvin in tinea capitis, possibly with a shorter duration of therapy. But for now, the old and familiar standby should remain the treatment of choice, according to Peter Mayser, M.D., senior physician, Justus Liebig University, Giessen, Germany.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
4
Top 5 Articles of the Week: December 7-12
5


















